CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- Open-market buys, last 90 days
- $9,705
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,705. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-14 | Dixon Jonathan V. General Counsel | Grant or award · Stock Option (Right to Buy) | +6,559 | 6,559 | ||
| 2025-03-14 | Adamchak Mark Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +3,029 | 3,029 | ||
| 2025-03-14 | Holmlin R. Erik President and CEO | Shares withheld for taxes | −198 | $3.47 | $687 | 1,783 |
| 2025-03-14 | Holmlin R. Erik President and CEO | Grant or award · Stock Option (Right to Buy) | +17,449 | 17,449 | ||
| 2025-03-14 | OLDAKOWSKI MARK Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +6,966 | 6,966 | ||
| 2025-03-14 | Chaubey Alka Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +6,966 | 6,966 | ||
| 2025-02-15 | OLDAKOWSKI MARK Chief Operating Officer | Shares withheld for taxes | −20 | $5.73 | $115 | 1,001 |
| 2025-02-15 | Dixon Jonathan V. General Counsel | Shares withheld for taxes | −6 | $5.73 | $34 | 294 |
| 2025-02-15 | Holmlin R. Erik President and CEO | Shares withheld for taxes | −51 | $5.73 | $292 | 1,981 |
| 2025-02-15 | Chaubey Alka Chief Medical Officer | Shares withheld for taxes | −18 | $5.73 | $103 | 737 |
| 2025-02-15 | Adamchak Mark Principal Accounting Officer | Shares withheld for taxes | −4 | $5.73 | $23 | 270 |
| 2024-10-01 | Adamchak Mark Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2024-09-11 | OLDAKOWSKI MARK Chief Operating Officer | Shares withheld for taxes | −3,568 | $0.48 | $2K | 61,283 |
| 2024-09-11 | Chaubey Alka Chief Medical Officer | Shares withheld for taxes | −3,075 | $0.48 | $1K | 45,323 |
| 2024-06-18 | Rajkovic Aleksandar Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-06-18 | Luderer Albert Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-06-18 | Vuori Kristiina MD Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-06-18 | BARKER DAVID L Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-06-18 | Wong Vincent Jung-Fai Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-06-18 | Mamuszka Hannah Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 |
Page 3 of 14 · 266 trades